ALX ONCOLOGY HOLDINGS INC Contracts & Agreements
35 Contracts & Agreements
- Business Finance (14 contracts)
- Business Operations (3)
- Human Resources (8)
- Uncategorized (10)
- Separation Agreement and Release between the Registrant and Sophia Randolph, M.D., Ph.D (Filed With SEC on November 7, 2024)
- Description of Securities (Filed With SEC on March 7, 2024)
- Third Amendment to Loan and Security Agreement, dated as of December 22, 2023, among Oxford Finance LLC, as collateral agent, the lenders party thereto, ALX Oncology Inc., as... (Filed With SEC on December 26, 2023)
- Amendment No. 1 to the Sales Agreement with Cantor and Credit Suisse, dated August 25, 2023 (Filed With SEC on November 13, 2023)
- Underwriting Agreement, dated as October 4, 2023, among ALX Oncology Holdings Inc. and the Representatives (Filed With SEC on October 6, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on October 6, 2023)
- Confirmatory Employment Letter between the Company and Jason Lettmann, dated September 5, 2023 (Filed With SEC on September 6, 2023)
- Confirmatory Employment Letter between the Company and Jaume Pons, dated September 5, 2023 (Filed With SEC on September 6, 2023)
- Second Amendment to Loan and Security Agreement, dated as of May 31, 2023 (Filed With SEC on August 10, 2023)
- Outside Director Compensation Policy (Filed With SEC on May 11, 2023)
- Loan and Security Agreement, dated as of October 27, 2022, among Oxford Finance LLC, as collateral agent, the lenders from time to time party thereto, ALX Oncology Inc., Alexo... (Filed With SEC on October 31, 2022)
- Description of Securities (Filed With SEC on February 28, 2022)
- Confirmatory Offer Letter between the Registrant and Shelly Pinto (Filed With SEC on February 28, 2022)
- Sales Agreement, dated December 17, 2021, by and among ALX Oncology Holdings Inc., Cantor Fitzgerald & Co., and Credit Suisse Securities (USA) LLC (Filed With SEC on December 17, 2021)
- Description of Securities (Filed With SEC on March 18, 2021)
- Form of Underwriting Agreement (Filed With SEC on December 7, 2020)
- Form of Underwriting Agreement (Filed With SEC on July 13, 2020)
- Amended and Restated 2020 Equity Incentive Plan and forms of agreements thereunder, to be in effect upon the completion of this offering (Filed With SEC on July 13, 2020)
- 2020 Employee Stock Purchase Plan, to be in effect upon the completion of this offering (Filed With SEC on July 13, 2020)
- Confirmatory Offer Letter between the Registrant and Jaume Pons, Ph.D. effective as of July 9, 2020 (Filed With SEC on July 13, 2020)
- Confirmatory Offer Letter between the Registrant and Nathan Caffo, effective as of July 9, 2020 (Filed With SEC on July 13, 2020)
- Confirmatory Offer Letter between the Registrant and Peter Garca, effective as of July 9, 2020 (Filed With SEC on July 13, 2020)
- Confirmatory Offer Letter between the Registrant and Steffen Pietzke, effective as of July 9, 2020 (Filed With SEC on July 13, 2020)
- Confirmatory Offer Letter between the Registrant and Sophia Randolph, M.D., Ph.D., effective as of July 9, 2020 (Filed With SEC on July 13, 2020)
- Executive Incentive Compensation Plan (Filed With SEC on July 13, 2020)
- Outside Director Compensation Policy (Filed With SEC on July 13, 2020)
- Form of Change in Control and Severance Agreement (Filed With SEC on July 13, 2020)
- Amended and Restated Investors Rights Agreement among the Registrant and certain of its stockholders, dated April 1, 2020 (Filed With SEC on June 26, 2020)
- Specimen common stock certificate of the Registrant (Filed With SEC on June 26, 2020)
- Form of Amended and Restated Warrant to Purchase Stock (Filed With SEC on June 26, 2020)
- Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (Filed With SEC on June 26, 2020)
- Exclusive (Equity) Agreement between the Registrant and The Board of Trustees of the Leland Stanford Junior University, effective as of March 24, 2015, as amended on April 24,... (Filed With SEC on June 26, 2020)
- Loan and Security Agreement, dated as of December 20, 2019, among the Registrant, certain of its affiliates, Silicon Valley Bank and WestRiver Innovation Lending Fund VIII, L.P.,... (Filed With SEC on June 26, 2020)
- Conformed Copy of Amended and Restated Research and Development Services Agreement, dated as of June 18, 2018, between ALX Oncology Inc. and Tollnine, Inc., incorporating... (Filed With SEC on June 26, 2020)
- Research and Development Services Agreement, dated as of June 25, 2020, between the Registrant and Tallac Therapeutics, Inc. (formerly known as Tollnine, Inc.) (Filed With SEC on June 26, 2020)
